GlassScriptPhysician profile
James B Mcpike
NPI 1700972015
$9,020.70
in general payments reported to CMS, 2019-2025
37 companies · $1,414 in 2025
The $1,414 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,340 · 2020: $1,103 · 2021: $2,491 · 2022: $245 · 2023: $333 · 2024: $1,096 · 2025: $1,414.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,747 · Travel and Lodging: $1,095.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,747.10 |
| Travel and Lodging | $1,095.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,404.53 | 2021-2025 | Pulseselect, Micra |
| Janssen Pharmaceuticals, INC | $809.38 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $592.01 | 2019-2025 | Watchman Flx |
| Abbott Laboratories | $586.65 | 2019-2025 | Ensite Precision, Ensite, Advisor |
| Amgen INC. | $574.94 | 2019-2024 | Repatha |
| Novartis Pharmaceuticals Corporation | $498.38 | 2019-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $442.32 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $230.19 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $206.07 | 2019-2024 | |
| Chiesi USA, INC. | $189.19 | 2019-2021 | |
| Pfizer INC. | $187.61 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $181.52 | 2019-2023 | Eliquis, Camzyos |
| Irhythm Technologies, INC. | $124.91 | 2019-2024 | Zio Xt Patch, Zio Monitor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $102.84 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $96.08 | 2019 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $92.66 | 2019-2020 | |
| Kiniksa Pharmaceuticals International, Plc | $61.02 | 2024 | Arcalyst |
| Medtronic Vascular, INC. | $53.65 | 2019-2020 | |
| Novo Nordisk INC | $52.89 | 2024 | Ozempic, Rybelsus |
| Abiomed | $49.95 | 2020-2023 | Impella |
| Lantheus Medical Imaging, INC. | $47.68 | 2023 | Definity |
| Tactile Systems Technology INC | $44.70 | 2024 | Entre Plus, Flexitouch Plus |
| Shockwave Medical, INC | $43.89 | 2020 | |
| Gilead Sciences, INC. | $43.47 | 2019 | |
| Edwards Lifesciences Corporation | $37.21 | 2019-2020 | |
| Heartflow, INC. | $35.50 | 2023 | Ffrct |
| Bard Peripheral Vascular, INC. | $33.35 | 2019-2020 | |
| Biotronik INC. | $29.89 | 2019 | |
| Recor Medical INC | $25.54 | 2024 | Paradise Renal Denervation System |
| Covidien LP | $23.98 | 2019 | |
| Daiichi Sankyo INC. | $22.00 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $21.60 | 2023 | Arcalyst |
| Cardinal Health 200 LLC | $21.45 | 2020 | |
| Braemar Manufacturing, LLC | $14.74 | 2019 | |
| Medicomp INC | $13.84 | 2019 | |
| Ge Healthcare | $12.55 | 2019 | |
| Medicure Pharma INC. | $12.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Mcpike listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.